title: Severe GHB withdrawal delirium managed with dexmedetomidine.
authors.affiliation: Western Sydney Local Health District, Sydney, NSW emma.tay@svha.org.au.
authors.forename: Emma My
authors.initials: EM
authors.lastname: Tay
authors.affiliation: Western Sydney Local Health District, Sydney, NSW.
authors.forename: Robert I
authors.initials: RI
authors.lastname: Graham
authors.affiliation: St Vincent's Hospital, Sydney, NSW.
authors.forename: Richard O
authors.initials: RO
authors.lastname: Day
mesh_terms: D003693:Delirium / Q000139:chemically induced*; D020927:Dexmedetomidine / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage* / Q000009:adverse effects; D012978:Sodium Oxybate / Q000009:adverse effects*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D055815:Young Adult
chemical_list: D006993:Hypnotics and Sedatives; D020927:Dexmedetomidine; D012978:Sodium Oxybate